LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | XMD11-85h | 0.04 | uM | LJP6 | 1 | P24 | 72 | hr | 1389 | 3116 | 5147 | 0.6054 | 0.5335 |
| MCF7 | XMD11-85h | 0.04 | uM | LJP6 | 2 | P24 | 72 | hr | 1389 | 4033 | 5447 | 0.7403 | 0.7171 |
| MCF7 | XMD11-85h | 0.04 | uM | LJP6 | 3 | P24 | 72 | hr | 1389 | 4594 | 5740 | 0.8003 | 0.7938 |
| MDA-MB-231 | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 1311 | 1592 | 5100 | 0.3122 | 0.1039 |
| MCF7 | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 1389 | 2744 | 6038 | 0.4544 | 0.3787 |
| MDA-MB-231 | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 1311 | 1672 | 5010 | 0.3337 | 0.1337 |
| MDA-MB-231 | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 1311 | 1530 | 5128 | 0.2983 | 0.0814 |